Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?

Onco Targets Ther · 2019 · PMC6485034 · PMID 31114242

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In addition, patients previously treated with hormonal therapy alone showed a trend to increased risk of progression versus those previously treated with chemotherapy (with or without hormonal therapy), but the difference was not statistically significant after adjustment for age, estrogen receptor (ER) and the possible prognostic marker, Ki67 status.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.